Dr Ralph Stewart (Auckland City Hospital, Auckland, NZ) provides a comprehensive overview of the New Zealand oxygen therapy in acute coronary syndromes (NZOTACS) trial.
1. What does NZOTACS aim to address?
2. What is the study design, inclusion criteria, and end points?
3. What were your findings?
4. How does this data compare to DETO2X-AMI?
Filmed on site at ESC 2019 by Radcliffe Cardiology
Videography: Mike Knight & Tom Green
Interviewer: Liam O'Neill